ActiQs
Mer att utforska

Verktyg för dig

Kombinationer Mina bevakningar

För professionella

Ämnesregister Källregister API & data
ActiQs / Forskning
PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för teriflunomide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar
Bibliografisk träff 2012-06-21

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.

Miller AE, O'Connor P, Wolinsky JS, Confavreux C, Kappos L, Olsson TP, Truffinet P, Wang L, D'Castro L, Comi G, Freedman MS, Teriflunomide Multiple Sclerosis Trial Group.

Mult Scler · clinical trial, phase iii; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1177/1352458512450354
Bibliografisk träff 2012-06-01

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

Fernandez O, Alvarez-Cermeno JC, Arroyo-Gonzalez R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, de las Heras V, Garcia-Merino JA, Hernandez-Perez MA, Izquierdo G, Meca-Lallana JE, Munoz-Garcia D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Rodriguez-Antiguedad A, Romero-Pinel L, Sanchez F, Tellez N, Tintore M, Montalban X, Post-ECTRIMS group.

Rev Neurol · research support, non-u.s. gov't; journal article
Bibliografisk träff 2012-05-23

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial.

Freedman MS, Wolinsky JS, Wamil B, Confavreux C, Comi G, Kappos L, Olsson TP, Miller A, Benzerdjeb H, Li H, Simonson C, O'Connor PW, Teriflunomide Multiple Sclerosis Trial Group and the MRI Analysis Center.

Neurology · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1212/wnl.0b013e318258f7d4
Bibliografisk träff 2012-02-03

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.

Confavreux C, Li DK, Freedman MS, Truffinet P, Benzerdjeb H, Wang D, Bar-Or A, Traboulsee AL, Reiman LE, O'Connor PW, Teriflunomide Multiple Sclerosis Trial Group.

Mult Scler · clinical trial, phase ii; comparative study; research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1177/1352458512436594
Bibliografisk träff 2011-10-01

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS, TEMSO Trial Group.

N Engl J Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1056/nejmoa1014656